Cancer and the FRA3B/FHIT fragile locus: it's a HIT
Authors:
Open Access
- 13 May 2003
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (10) , 1501-1506
Abstract
The FHIT gene encompassing the most active common human chromosomal fragile region, FRA3B, was discovered in 1996 and proposed as a tumour suppressor gene for important human cancers. Seven years and more than 350 reports later, early questions concerning its tumour suppressor role have been answered. Recent studies on the role of Fhit loss in major types of human cancers report association with high proliferative and low apoptotic indices, node positivity, loss of mismatch repair protein, likelihood of progression and reduced survival.Keywords
This publication has 42 references indexed in Scilit:
- Multiple molecular alterations of FHIT in betel‐associated oral carcinomaThe Journal of Pathology, 2002
- FRA3B and other common fragile sites: the weakest linksNature Reviews Cancer, 2001
- Altered Expression of the Fragile Histidine Triad Gene in Primary Gastric AdenocarcinomasBiochemical and Biophysical Research Communications, 2001
- FHIT gene therapy prevents tumor development in Fhit-deficient miceProceedings of the National Academy of Sciences, 2001
- Analysis of Intratumoral Heterogeneity of Chromosome 3p Deletions and Genetic Evidence of Polyclonal Origin of Cervical Squamous CarcinomaLaboratory Investigation, 2001
- Frequent Altered Expression of Fragile Histidine Triad Protein in Human Colorectal AdenomasBiochemical and Biophysical Research Communications, 2000
- Muir–Torre-like syndrome in Fhit-deficient miceProceedings of the National Academy of Sciences, 2000
- Clinicopathologic Features andFHITGene Expression in Sporadic Colorectal AdenocarcinomasScandinavian Journal of Gastroenterology, 2000
- THE ROLE OF THE FHIT/FRA3B LOCUS IN CANCERAnnual Review of Genetics, 1998
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996